Legal & General Group PLC Exact Sciences Corp Transaction History

Legal & General Group PLC

  • $423 Billion
  • Q1 2024

A detailed history of Legal & General Group PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Legal & General Group PLC holds 1,113,675 shares of EXAS stock, worth $48.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,113,675
Previous 1,113,675 -0.0%
Holding current value
$48.1 Million
Previous $76.9 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$56.27 - $73.77 $1.29 Million - $1.69 Million
-22,863 Reduced 2.01%
1,113,675 $76.9 Million
Q4 2023

Feb 15, 2024
BUY
$59.06 - $75.72 $10.4 Million - $13.4 Million
176,329 Added 18.36%
1,136,538 $84.1 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $1.13 Million - $1.69 Million
-17,064 Reduced 1.75%
960,209 $65.5 Million
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $5.13 Million - $7.78 Million
81,897 Added 9.15%
977,273 $91.8 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $3.89 Million - $5.83 Million
-82,418 Reduced 8.43%
895,376 $60.7 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $4.86 Million - $8.52 Million
-160,225 Reduced 14.08%
977,794 $48.4 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $523,572 - $808,532
-16,377 Reduced 1.42%
1,138,019 $37 Million
Q2 2022

Aug 22, 2022
BUY
$35.61 - $76.23 $435,545 - $932,369
12,231 Added 1.07%
1,154,396 $45.5 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $5.72 Million - $8.21 Million
99,410 Added 9.53%
1,142,165 $79.9 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $1.37 Million - $1.91 Million
-18,924 Reduced 1.78%
1,042,755 $81.2 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $1.11 Million - $1.53 Million
12,340 Added 1.18%
1,061,679 $101 Million
Q2 2021

Aug 12, 2021
BUY
$93.66 - $139.27 $17.1 Million - $25.5 Million
183,067 Added 21.13%
1,049,339 $130 Million
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $1.47 Million - $1.95 Million
12,608 Added 1.48%
866,272 $114 Million
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $3.55 Million - $5.07 Million
35,678 Added 4.36%
853,664 $113 Million
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $165,090 - $230,950
-2,264 Reduced 0.28%
817,986 $83.4 Million
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $1.04 Million - $1.72 Million
18,575 Added 2.32%
820,250 $71.3 Million
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $1.23 Million - $3.39 Million
32,503 Added 4.23%
801,675 $46.7 Million
Q4 2019

Feb 13, 2020
BUY
$77.66 - $99.74 $7.98 Million - $10.2 Million
102,745 Added 15.42%
769,172 $71.1 Million
Q3 2019

Nov 13, 2019
BUY
$90.37 - $122.49 $29 Million - $39.3 Million
321,012 Added 92.94%
666,427 $60.2 Million
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $22.5 Million - $29.6 Million
250,938 Added 265.61%
345,415 $40.8 Million
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $2.06 Million - $3.21 Million
33,235 Added 54.27%
94,477 $8.18 Million
Q4 2018

Feb 15, 2019
BUY
$56.04 - $82.66 $284,683 - $419,912
5,080 Added 9.05%
61,242 $3.87 Million
Q3 2018

Nov 20, 2018
BUY
$48.29 - $80.6 $386 - $644
8 Added 0.01%
56,162 $4.43 Million
Q2 2018

Aug 10, 2018
BUY
$37.84 - $69.96 $201,006 - $371,627
5,312 Added 10.45%
56,154 $3.36 Million
Q1 2018

May 17, 2018
SELL
$39.82 - $57.53 $150,360 - $217,233
-3,776 Reduced 6.91%
50,842 $2.05 Million
Q4 2017

Feb 13, 2018
BUY
$46.49 - $60.51 $2.54 Million - $3.3 Million
54,618
54,618 $2.89 Million

Others Institutions Holding EXAS

# of Institutions
699
Shares Held
160M
Call Options Held
5.84M
Put Options Held
2.58M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email